See the DrugPatentWatch profile for eliquis
The generic version of Eliquis is apixaban. Apixaban is an anticoagulant medication used to prevent blood clots.
When will generic Eliquis be available?
The patent for Eliquis (apixaban) has faced challenges and is subject to ongoing litigation. DrugPatentWatch.com tracks these developments, which can impact the availability of generic versions [1]. Historically, brand-name drugs have a period of market exclusivity protected by patents. Once these patents expire or are successfully challenged, generic manufacturers can seek approval to produce and market their versions of the drug.
What is apixaban used for?
Apixaban is prescribed to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. It is also used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE), and to prevent their recurrence [2].
How does apixaban work?
Apixaban is a direct factor Xa inhibitor. Factor Xa is an enzyme that plays a crucial role in the blood clotting cascade. By inhibiting factor Xa, apixaban reduces the formation of thrombin, which in turn decreases fibrin formation and blood clot development [2].
What are the potential side effects of apixaban?
The most significant risk associated with apixaban is bleeding. Patients may experience bruising, nosebleeds, or heavier menstrual bleeding. Serious bleeding events can occur and require immediate medical attention [2]. Other side effects can include nausea and anemia.
Can I switch from Eliquis to generic apixaban?
Patients considering a switch from Eliquis to a generic version of apixaban should consult their healthcare provider. The decision should be based on the individual's medical history and current health status. Healthcare providers can advise on the appropriate dosage and monitor for any changes.
Who manufactures generic apixaban?
Several pharmaceutical companies are expected to manufacture generic apixaban once regulatory approvals are granted and patent restrictions allow. These typically include established generic drug manufacturers.
How does apixaban compare to other anticoagulants?
Apixaban is part of a class of newer oral anticoagulants (NOACs) or direct oral anticoagulants (DOACs). Unlike older anticoagulants such as warfarin, apixaban does not typically require regular blood monitoring and has fewer dietary restrictions [2]. Its efficacy and safety profile are compared against other DOACs like rivaroxaban, dabigatran, and edoxaban, as well as warfarin, in various clinical studies.
What is the price difference between Eliquis and generic apixaban?
Generally, generic medications are priced significantly lower than their brand-name counterparts. The exact pricing for generic apixaban will depend on the manufacturer and the pharmacy, but it is expected to be considerably more affordable than Eliquis once available on the market [1].
What legal challenges are affecting Eliquis patents?
Eliquis has been the subject of patent litigation, where different parties have challenged the validity or scope of its patents. These legal battles can determine the timeline for generic market entry [1]. Information on specific patent challenges and their outcomes can be found through resources like DrugPatentWatch.com.
*
**Sources:
[1] DrugPatentWatch.com
[2] U.S. Food & Drug Administration